
Testimonials
Client Testimonials for Our Clinical Research Solution

We unified our clinical research workflows enterprise-wide using Jeeva, enabling our small team to efficiently manage all studies with highly responsive support. We are saving 60% time effort across all clinical trials.
Luma Melo, PhD, MSc, MBA, MA
Taxa technologies

Jeeva gave us exactly the configurations we needed for our Pivotal clinical trials. I appreciate the functionality of the system.
Mihaela Plesa, BA, CCRP
Director of Research Projects at Frantz Viral Therapeutics

There is an urgent need for validated tools to help ensure the continuity and integrity of clinical trial operations during and beyond the pandemic.
Frank Sasinowski, JD, MPH
A Legendary Leader in Rare Diseases and Orphan Drugs Regulation

We are pleased to provide financial support - both in the form of a grant and an equity investment - to Jeeva. Jeeva is an excellent example of the kind of startup we look to support and pursuing an enormous market opportunity. We wish Dr. Rajasimha and his team the best of luck as they continue to build this company.
Sean Mallon
Vice President, Virginia Innovation Partnership Corporation (VIPC)

Jeeva is a leader in the clinical trials software industry, with faster patient recruitment, focusing on global patient engagement.
Christiaan Engstrom
Founder, Bullpen Club

Jeeva is backed by excellent customer service. We are enjoying our seamless transition to this platform for our longitudinal cohort study. Flexibility in programming.
Dr. Lawrence Cheskin, MD
Professor and Chair, Nutrition and Food Studies, George Mason University

Together, we can significantly reduce trial timelines and improve patient outcomes across key therapeutic areas.
Sunil Tadepalli, MD
CEO, Labnetworx

We are thrilled to partner with Jeeva to bring next-generation efficiencies to clinical research. The need for AI-driven automation in clinical trials has never been greater, and a unified CTMS approach is exactly what the industry needs
Gurudath Gurjal, MSc
Director, ClinTrek

Luma Melo, PhD, MSc, MBA, MA
Taxa technologies

Mihaela Plesa, BA, CCRP
Director of Research Projects at Frantz Viral Therapeutics

We are pleased to collaborate with Jeeva for the eCOA module for our investigator initiated observational study to understand toileting use by individuals with certain brain disorders
Dr. Terry Jo Bichell
CombinedBrain

Jeeva is a best-in-class solution for gathering clinical information with best-in-class customer service—two thumbs up.
David Hirsch
Founder, Special Father's Network, 21st Century Dads Foundation

Jeeva's easy-to-use software interfaces and detailed user manual are backed by outstanding support team! Jeeva's technology platform enables us to serve patients globally in their native language.
Nisha Venugopal, Ph.D
Associate Director, Patient Focused Research Programs, Indo US Organization for Rare Diseases

Jeeva platform & service is aligned with our vision to making CAR-T cell therapies affordable in emerging markets.
Rahul Purwar
Founder at ImmunoACT

Rare disease trials are already complex enough without the added burden of fragmented trial management. Jeeva’s AI-powered CTMS offers a way to streamline operations and ensure regulatory compliance.”
Robert Freishtat, MD
President of Uncommon Cures

Veronica Bubb, PhD
President & Principal Biostatistical Consultant ALTRU Clinical Research

In looking for a software partner, our research coordinators and investigators in the field could call the Jeeva team anytime, get reliable support, and have reassurance as we enroll patients on the go. You can count on Jeeva when time is of the essence in operationalizing a clinical trial.
Dr. Emmanuel Gorospe
Chief Medical Officer of KCRS

We need to bring healthcare and product development costs down, especially in the developing world. Clinical trial costs are a significant part of product development costs. We are confident that by partnering with Jeeva, we can find the correct value-for-money proposition without compromising quality.
Shirish Arya
Director of Strategy at ImmunoACT

We are proud that Jeeva emerged as #1 on the National Science Foundation (NSF) Innovation-Corps Program leaderboard.
Josh Green, PMP
Director ICAP, Small Business Development Center, George Mason University

Jeeva is a game-changer for our rare diseases site/CRO. It is unfair to expect patients or healthy volunteers to visit a hospital or clinic when it is not necessary when a task can be effectively completed safely, remotely, and from the comfort of where they live.
Marshall Summar, MD, Ph.D
CEO, Uncommon Cures LLC

Jeeva's simple and elegant video consenting solution saves me hundreds of hours of repetitive process of obtaining informed consent from study participants
Kimberly Chapman, MD, Ph.D.
Principal Investigator, Childrens National Medical Center

Having evaluated numerous clinical trial platforms, Jeeva was refreshing in its vision to engage underrepresented minorities, focus on rare diseases, and collaborative approach beyond technology. We are eager to enable patient education, recruitment, and retention in rare disease clinical studies such as patient registries and cell/gene therapies.
Sara Tylosky, CEO
CEO, Farmacon Global

We unified our clinical research workflows enterprise-wide using Jeeva, enabling our small team to efficiently manage all studies with highly responsive support. We are saving 60% time effort across all clinical trials.
Luma Melo, PhD, MSc, MBA, MA
Taxa technologies

Luma Melo, PhD, MSc, MBA, MA
Taxa technologies

Veronica Bubb, PhD
President & Principal Biostatistical Consultant ALTRU Clinical Research

Jeeva gave us exactly the configurations we needed for our Pivotal clinical trials. I appreciate the functionality of the system.
Mihaela Plesa, BA, CCRP
Director of Research Projects at Frantz Viral Therapeutics

Mihaela Plesa, BA, CCRP
Director of Research Projects at Frantz Viral Therapeutics

In looking for a software partner, our research coordinators and investigators in the field could call the Jeeva team anytime, get reliable support, and have reassurance as we enroll patients on the go. You can count on Jeeva when time is of the essence in operationalizing a clinical trial.
Dr. Emmanuel Gorospe
Chief Medical Officer of KCRS

There is an urgent need for validated tools to help ensure the continuity and integrity of clinical trial operations during and beyond the pandemic.
Frank Sasinowski, JD, MPH
A Legendary Leader in Rare Diseases and Orphan Drugs Regulation

We are pleased to collaborate with Jeeva for the eCOA module for our investigator initiated observational study to understand toileting use by individuals with certain brain disorders
Dr. Terry Jo Bichell
CombinedBrain

We need to bring healthcare and product development costs down, especially in the developing world. Clinical trial costs are a significant part of product development costs. We are confident that by partnering with Jeeva, we can find the correct value-for-money proposition without compromising quality.
Shirish Arya
Director of Strategy at ImmunoACT

We are pleased to provide financial support - both in the form of a grant and an equity investment - to Jeeva. Jeeva is an excellent example of the kind of startup we look to support and pursuing an enormous market opportunity. We wish Dr. Rajasimha and his team the best of luck as they continue to build this company.
Sean Mallon
Vice President, Virginia Innovation Partnership Corporation (VIPC)

Jeeva is a best-in-class solution for gathering clinical information with best-in-class customer service—two thumbs up.
David Hirsch
Founder, Special Father's Network, 21st Century Dads Foundation

We are proud that Jeeva emerged as #1 on the National Science Foundation (NSF) Innovation-Corps Program leaderboard.
Josh Green, PMP
Director ICAP, Small Business Development Center, George Mason University

Jeeva is a leader in the clinical trials software industry, with faster patient recruitment, focusing on global patient engagement.
Christiaan Engstrom
Founder, Bullpen Club

Jeeva's easy-to-use software interfaces and detailed user manual are backed by outstanding support team! Jeeva's technology platform enables us to serve patients globally in their native language.
Nisha Venugopal, Ph.D
Associate Director, Patient Focused Research Programs, Indo US Organization for Rare Diseases

Jeeva is a game-changer for our rare diseases site/CRO. It is unfair to expect patients or healthy volunteers to visit a hospital or clinic when it is not necessary when a task can be effectively completed safely, remotely, and from the comfort of where they live.
Marshall Summar, MD, Ph.D
CEO, Uncommon Cures LLC

Jeeva is backed by excellent customer service. We are enjoying our seamless transition to this platform for our longitudinal cohort study. Flexibility in programming.
Dr. Lawrence Cheskin, MD
Professor and Chair, Nutrition and Food Studies, George Mason University

Jeeva platform & service is aligned with our vision to making CAR-T cell therapies affordable in emerging markets.
Rahul Purwar
Founder at ImmunoACT

Jeeva's simple and elegant video consenting solution saves me hundreds of hours of repetitive process of obtaining informed consent from study participants
Kimberly Chapman, MD, Ph.D.
Principal Investigator, Childrens National Medical Center

Together, we can significantly reduce trial timelines and improve patient outcomes across key therapeutic areas.
Sunil Tadepalli, MD
CEO, Labnetworx

Rare disease trials are already complex enough without the added burden of fragmented trial management. Jeeva’s AI-powered CTMS offers a way to streamline operations and ensure regulatory compliance.”
Robert Freishtat, MD
President of Uncommon Cures

Having evaluated numerous clinical trial platforms, Jeeva was refreshing in its vision to engage underrepresented minorities, focus on rare diseases, and collaborative approach beyond technology. We are eager to enable patient education, recruitment, and retention in rare disease clinical studies such as patient registries and cell/gene therapies.
Sara Tylosky, CEO
CEO, Farmacon Global

We are thrilled to partner with Jeeva to bring next-generation efficiencies to clinical research. The need for AI-driven automation in clinical trials has never been greater, and a unified CTMS approach is exactly what the industry needs
Gurudath Gurjal, MSc
Director, ClinTrek

We unified our clinical research workflows enterprise-wide using Jeeva, enabling our small team to efficiently manage all studies with highly responsive support. We are saving 60% time effort across all clinical trials.
Luma Melo, PhD, MSc, MBA, MA
Taxa technologies

Veronica Bubb, PhD
President & Principal Biostatistical Consultant ALTRU Clinical Research

Mihaela Plesa, BA, CCRP
Director of Research Projects at Frantz Viral Therapeutics

There is an urgent need for validated tools to help ensure the continuity and integrity of clinical trial operations during and beyond the pandemic.
Frank Sasinowski, JD, MPH
A Legendary Leader in Rare Diseases and Orphan Drugs Regulation

We need to bring healthcare and product development costs down, especially in the developing world. Clinical trial costs are a significant part of product development costs. We are confident that by partnering with Jeeva, we can find the correct value-for-money proposition without compromising quality.
Shirish Arya
Director of Strategy at ImmunoACT

Jeeva is a best-in-class solution for gathering clinical information with best-in-class customer service—two thumbs up.
David Hirsch
Founder, Special Father's Network, 21st Century Dads Foundation

Jeeva is a leader in the clinical trials software industry, with faster patient recruitment, focusing on global patient engagement.
Christiaan Engstrom
Founder, Bullpen Club

Jeeva is a game-changer for our rare diseases site/CRO. It is unfair to expect patients or healthy volunteers to visit a hospital or clinic when it is not necessary when a task can be effectively completed safely, remotely, and from the comfort of where they live.
Marshall Summar, MD, Ph.D
CEO, Uncommon Cures LLC

Jeeva platform & service is aligned with our vision to making CAR-T cell therapies affordable in emerging markets.
Rahul Purwar
Founder at ImmunoACT

Together, we can significantly reduce trial timelines and improve patient outcomes across key therapeutic areas.
Sunil Tadepalli, MD
CEO, Labnetworx

Having evaluated numerous clinical trial platforms, Jeeva was refreshing in its vision to engage underrepresented minorities, focus on rare diseases, and collaborative approach beyond technology. We are eager to enable patient education, recruitment, and retention in rare disease clinical studies such as patient registries and cell/gene therapies.
Sara Tylosky, CEO
CEO, Farmacon Global

Luma Melo, PhD, MSc, MBA, MA
Taxa technologies

Jeeva gave us exactly the configurations we needed for our Pivotal clinical trials. I appreciate the functionality of the system.
Mihaela Plesa, BA, CCRP
Director of Research Projects at Frantz Viral Therapeutics

In looking for a software partner, our research coordinators and investigators in the field could call the Jeeva team anytime, get reliable support, and have reassurance as we enroll patients on the go. You can count on Jeeva when time is of the essence in operationalizing a clinical trial.
Dr. Emmanuel Gorospe
Chief Medical Officer of KCRS

We are pleased to collaborate with Jeeva for the eCOA module for our investigator initiated observational study to understand toileting use by individuals with certain brain disorders
Dr. Terry Jo Bichell
CombinedBrain

We are pleased to provide financial support - both in the form of a grant and an equity investment - to Jeeva. Jeeva is an excellent example of the kind of startup we look to support and pursuing an enormous market opportunity. We wish Dr. Rajasimha and his team the best of luck as they continue to build this company.
Sean Mallon
Vice President, Virginia Innovation Partnership Corporation (VIPC)

We are proud that Jeeva emerged as #1 on the National Science Foundation (NSF) Innovation-Corps Program leaderboard.
Josh Green, PMP
Director ICAP, Small Business Development Center, George Mason University

Jeeva's easy-to-use software interfaces and detailed user manual are backed by outstanding support team! Jeeva's technology platform enables us to serve patients globally in their native language.
Nisha Venugopal, Ph.D
Associate Director, Patient Focused Research Programs, Indo US Organization for Rare Diseases

Jeeva is backed by excellent customer service. We are enjoying our seamless transition to this platform for our longitudinal cohort study. Flexibility in programming.
Dr. Lawrence Cheskin, MD
Professor and Chair, Nutrition and Food Studies, George Mason University

Jeeva's simple and elegant video consenting solution saves me hundreds of hours of repetitive process of obtaining informed consent from study participants
Kimberly Chapman, MD, Ph.D.
Principal Investigator, Childrens National Medical Center

Rare disease trials are already complex enough without the added burden of fragmented trial management. Jeeva’s AI-powered CTMS offers a way to streamline operations and ensure regulatory compliance.”
Robert Freishtat, MD
President of Uncommon Cures

We are thrilled to partner with Jeeva to bring next-generation efficiencies to clinical research. The need for AI-driven automation in clinical trials has never been greater, and a unified CTMS approach is exactly what the industry needs
Gurudath Gurjal, MSc
Director, ClinTrek
